186 related articles for article (PubMed ID: 23622613)
81. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
82. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
[TBL] [Abstract][Full Text] [Related]
83. Management of aortic valve insufficiency in patients supported by long-term continuous flow left ventricular assist devices.
Morgan JA; Brewer RJ; Nemeh HW; Henry SE; Neha N; Williams CT; Lanfear DE; Tita C; Paone G
Ann Thorac Surg; 2012 Nov; 94(5):1710-2. PubMed ID: 23098948
[TBL] [Abstract][Full Text] [Related]
84. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
Urban M; Pirk J; Dorazilova Z; Netuka I
Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
[TBL] [Abstract][Full Text] [Related]
85. Inhaled Desmopressin for Refractory Gastrointestinal Bleeding in a Patient With a HeartMate II Left Ventricular Assist Device.
Hollis IB; Chen SL; Chang PP; Katz JN
ASAIO J; 2017; 63(4):e47-e49. PubMed ID: 27556142
[TBL] [Abstract][Full Text] [Related]
86. Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome.
Thompson JL; Schaff HV; Dearani JA; Park SJ; Sundt TM; Suri RM; Blackshear JL; Daly RC
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):112-6. PubMed ID: 21864855
[TBL] [Abstract][Full Text] [Related]
87. Is resternotomy a risk for continuous-flow left ventricular assist device outcomes?
Tsiouris A; Brewer RJ; Borgi J; Hodari A; Nemeh HW; Cogan CM; Paone G; Morgan JA
J Card Surg; 2013 Jan; 28(1):82-7. PubMed ID: 23240608
[TBL] [Abstract][Full Text] [Related]
88. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
[TBL] [Abstract][Full Text] [Related]
89. Ventricular assist device in patients with prosthetic heart valves.
Mokashi SA; Schmitto JD; Lee LS; Rawn JD; Bolman RM; Shekar PS; Couper GS; Chen FY
Artif Organs; 2010 Nov; 34(11):1030-4. PubMed ID: 21137108
[TBL] [Abstract][Full Text] [Related]
90. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
91. Characteristics of gastrointestinal bleeding after placement of continuous-flow left ventricular assist device: a case series.
Marsano J; Desai J; Chang S; Chau M; Pochapin M; Gurvits GE
Dig Dis Sci; 2015 Jun; 60(6):1859-67. PubMed ID: 25616611
[TBL] [Abstract][Full Text] [Related]
92. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
93. Risk factors predictive of right ventricular failure after left ventricular assist device implantation.
Drakos SG; Janicki L; Horne BD; Kfoury AG; Reid BB; Clayson S; Horton K; Haddad F; Li DY; Renlund DG; Fisher PW
Am J Cardiol; 2010 Apr; 105(7):1030-5. PubMed ID: 20346326
[TBL] [Abstract][Full Text] [Related]
94. Low incidence of bleeding-related morbidity with left ventricular assist device implantation in the current era.
Krishan K; Nair A; Pinney S; Adams D; Anyanwu AC
Artif Organs; 2012 Aug; 36(8):746-51. PubMed ID: 22607225
[TBL] [Abstract][Full Text] [Related]
95. Left Ventricular Assist Device-Associated Gastrointestinal Bleeding: Recognition of an Iatrogenic Etiology on
Jamison DK; Yang AF; Arsanjani R; Zhou Y; Yang M
J Nucl Med Technol; 2019 Jun; 47(2):169-170. PubMed ID: 30700535
[No Abstract] [Full Text] [Related]
96. [Gastrointestinal bleeding (introduction)].
Koyama H; Sasaki J; Niwa H
Nihon Rinsho; 1998 Sep; 56(9):2314-8. PubMed ID: 9780712
[TBL] [Abstract][Full Text] [Related]
97. GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
Draper KV; Huang RJ; Gerson LB
Gastrointest Endosc; 2014 Sep; 80(3):435-446.e1. PubMed ID: 24975405
[TBL] [Abstract][Full Text] [Related]
98. Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy.
Gutsche JT; Atluri P; Augoustides JG
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):939-43. PubMed ID: 24054188
[No Abstract] [Full Text] [Related]
99. Hemorrhoids screening and treatment prior to LVAD: is it a necessity?
Skouri H; Shurrab M; Zahnan J; Deeba S; Sfeir P; Gharzuddin W; Haj-Yahia S
J Cardiothorac Surg; 2016 Apr; 11(1):58. PubMed ID: 27067282
[TBL] [Abstract][Full Text] [Related]
100. The Diagnostic Yield of Repeated Endoscopic Evaluation in Patients with Gastrointestinal Bleeding and Left Ventricular Assist Devices.
Dakik HK; McGhan AA; Chiu ST; Patel CB; Milano CA; Rogers JG; Chow SC; Wild DM
Dig Dis Sci; 2016 Jun; 61(6):1603-10. PubMed ID: 26809869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
